Leukemia & Lymphoma
Overview
Leukemia & Lymphoma is a renowned peer-reviewed medical journal that focuses on the latest research and advancements in the field of hematological malignancies. It covers a wide range of topics including diagnosis, treatment, and management of leukemia, lymphoma, myeloma, and related disorders. With its comprehensive and authoritative content, the journal serves as a valuable resource for clinicians, researchers, and healthcare professionals involved in the care of patients with blood cancers.
Details
Details
Abbr.
Leuk Lymphoma
Start
1989
End
Continuing
Frequency
Fourteen issues a year, 2019-
p-ISSN
1042-8194
e-ISSN
1029-2403
Country
United States
Language
English
Specialties
Oncology
Hematology
Hematology
Metrics
Metrics
h-index / Ranks: 3004
102
SJR / Ranks: 5368
790
CiteScore / Ranks: 6699
4.00
JIF / Ranks: 4138
2.6
Recent Articles
11.
Lee J, Song S, Shin Y, Kim S, Yoo Y, Joo J, et al.
Leuk Lymphoma
. 2025 Mar;
:1-8.
PMID: 40048624
This study evaluated the efficacy and safety of 20.0 Gy versus 30.6 Gy radiotherapy for conjunctival MALT lymphoma in 76 lesions treated between 2010 and 2022. The 30.6 Gy group...
12.
Kim M, Cho J, Kim W, Kim S, Yoon S
Leuk Lymphoma
. 2025 Mar;
:1-12.
PMID: 40029982
This is a retrospective study conducted to determine whether there is an optimal regimen for elderly diffuse large B-cell lymphoma (DLBCL) patients. We selected patients aged 80 years or older...
13.
You Y, Suolitiken D, Wu L, Pi Y, Chen L, Song D, et al.
Leuk Lymphoma
. 2025 Mar;
:1-8.
PMID: 40028784
Hemophagocytic lymphohistiocytosis (HLH) is a fatal multi-systemic disorder. Patients with HLH are more prone to bleeding, which implies a poor outcome. The objective was to investigate the efficacy of recombinant...
14.
Tan M, Lasica M, Donati V, Rady K, Nagarethinam M, Fleming S, et al.
Leuk Lymphoma
. 2025 Feb;
:1-7.
PMID: 40013747
Paediatric-inspired acute lymphoblastic leukaemia (ALL) regimens have led to improved leukaemic outcomes in adults. However, avascular necrosis (AVN) has emerged as a debilitating orthopaedic complication. AVN is likely multifactorial, with...
15.
Gurumurthi A, Henshaw L, Falchi L, Moskowitz A, Noy A, Seo S, et al.
Leuk Lymphoma
. 2025 Feb;
:1-4.
PMID: 39992225
No abstract available.
16.
Abeyakoon C, Ting E, Khan S, Maganti M, Bhella S, Crump M, et al.
Leuk Lymphoma
. 2025 Feb;
:1-5.
PMID: 39985180
No abstract available.
17.
Gruessner C, Wiestner A, Sun C
Leuk Lymphoma
. 2025 Feb;
:1-13.
PMID: 39972943
Bruton tyrosine kinase (BTK), an essential component of the B-cell receptor (BCR) signaling pathway, is a validated target in chronic lymphocytic leukemia. Ibrutinib, acalabrutinib, and zanubrutinib are covalent BTK inhibitors...
18.
Shestakova A, Haghighi N, Zhang Y, Tarabay J, Evans M, Burtsev A, et al.
Leuk Lymphoma
. 2025 Feb;
:1-6.
PMID: 39966108
No abstract available.
19.
Loh Z, Ashby M, Rahman M, Wong E, Ong D, Morgan S, et al.
Leuk Lymphoma
. 2025 Feb;
:1-4.
PMID: 39966107
No abstract available.
20.
Bellani V, Mora B, Iurlo A, Passamonti F
Leuk Lymphoma
. 2025 Feb;
:1-13.
PMID: 39960832
Calreticulin (CALR) is a chaperone protein that plays a crucial role in protein folding quality control and calcium homeostasis. Mutations in result in a mutated protein lacking key calcium-binding sites...